Glaukos Corporation (NYSE: GKOS)
Health Care · Health Care Equipment & Supplies · US
$167.92
+1.35% today · +100.7% 1Y
Glaukos Corporation (NYSE: GKOS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $9.77B and employs 1,094 people.
Over the last twelve months the share price has gained 100.7%, trading between 73.16 and 191.62.
Tweenvest scores Glaukos Corporation across four factors: quality 62/100, value 41/100, growth 92/100. Its strongest factor is growth.
GKOS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.77B
- Revenue (TTM)
- $612.84M
- P/E
- —
- EPS
- -3.25
- Dividend yield
- —
- Beta (5Y)
- 0.70
- 52-week high
- $191.62
- 52-week low
- $73.16
- Avg volume (3M)
- —
- Shares outstanding
- 58.96M
- Employees
- 1,094
- Next earnings
- —
About Glaukos Corporation
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
- ISIN
- US3773221029
- Founded
- 1998
- Listed since
- Jun 25, 2015
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Demant A/SCPSE: DEMANT | $10.78B | Dkr350.80 | +2.81% |
| The Cooper Companies, Inc.NasdaqGS: COO | $10.34B | $55.45 | +1.99% |
| Align Technology, Inc.NasdaqGS: ALGN | $10.14B | $143.13 | +0.29% |
| Globus Medical, Inc.NYSE: GMED | $10.02B | $75.78 | +1.51% |
| Insulet CorporationNasdaqGS: PODD | $9.38B | $137.90 | +1.94% |
| Sysmex CorporationTSE: 6869 | $7.09B | ¥1,855.00 | -1.43% |
| Getinge AB (publ)OM: GETI B | $6.90B | Skr253.20 | +2.76% |
| Lantheus Holdings, Inc.NasdaqGM: LNTH | $6.54B | $100.21 | +0.06% |
Figures last refreshed Oct 11, 2026.